Literature DB >> 34309140

Ostomy 101 for Dermatologists: Managing Peristomal Skin Diseases.

Peyton C Morss-Walton1, Julie Z Yi2, Mary-Ellen Gunning3, Jean S McGee4,5.   

Abstract

An estimated 1 million North Americans live with ostomies, with up to 80% of ostomy patients developing stoma-related skin morbidities. While ostomy nurses are often the first line of management, dermatologists may be involved in the care of ostomy patients with complex or persistent peristomal skin complications. Therefore, an understanding of the ostomy apparatus and possible peristomal skin conditions that may arise allows dermatologists to identify skin complications early and work effectively with a multidisciplinary team. In this article, we aim to review the ostomy apparatus, discuss the differential diagnosis, and provide practical guidelines for the management of peristomal skin conditions. Pubmed, Ovid Medline, and Google Scholar were searched for relevant articles assessing peristomal skin complications and their management. Peristomal skin complications may be local (e.g., contact dermatitis, infections, fistulas, and mechanical trauma) or secondary to systemic disease (e.g., inflammatory bowel diseases, pyoderma gangrenosum, and psoriasis). Ensuring appropriate ostomy fit and proper use of ostomy accessory products helps to reduce effluent leakage and prevent damage to the peristomal skin. For persistent peristomal skin conditions, corticosteroid sprays, systemic therapies, and surgical interventions may be warranted. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  MASD; contact dermatitis; infection; pressure ulcer; pyoderma gangrenosum; stoma

Year:  2021        PMID: 34309140     DOI: 10.1111/dth.15069

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  1 in total

1.  Peristomal granulation tissue mimicking peristomal pyoderma gangrenosum in the context of urine-diverting ostomies.

Authors:  Brett D McLarney; Simo Huang; Sylvia Hsu
Journal:  JAAD Case Rep       Date:  2022-08-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.